Nutraceuticals - a natural part of modern healthcare  
ICMAN5
Queensland Life Sciences Industry Excellence Award
  Queensland Life Sciences Industry Excellence Award   Print  

 

VOTING HAS NOW CLOSED

   
  Biographies   Print  
  Dr. Cherrell Hirst AO MBBS, BEdSt, D.Univ (Hon), FAICD - CEO, The Queensland BioCapital Funds
Dr Hirst’s initial career focus was in clinical medicine and for almost 20 years she was Director of the Wesley Breast Clinic. Her interest in the value of education took her to the Council of QUT in 1990 and she was Chancellor from 1994-2004. Research related to Cherrell’s clinical work and her exposure to research at QUT drew her to biotechnology. Her current roles in the sector include Member of the Queensland Smart State Council, Director of Impedimed Ltd, Director of Xenome Ltd (since 2007), Director of Tissue Therapies Ltd (since 2009), and Director of Hatchtech Pty Ltd (since 2010). Previously she was Chair of Peplin Ltd and a member of the AusIndustry Biological Committee for 6 years. Cherrell is a member of the Queensland Biotechnology Reference Group. She is a voice for Biotechnology on Queensland’s Smart State Council and has served as speaker and on expert panels at conferences and other forums in the area of biotechnology - especially life sciences. In 2009 she was an elected as a member to the Academy of Technological Sciences and Engineering. In 2010 she accepted the role of Chair with the Tropical Health Alliance and has served as a Reviewer of Academic Research Institutes.
 

Prof. Ron Quinn - Director, Eskitis Institute, Griffith University
In 1990, Professor Ron Quinn was at the forefront of efforts to establish a Life Sciences Industry in Queensland, when he established a Centre within Griffith University. This Centre achieved the largest investment ($A 101 million) by a major Pharmaceutical company in the State.
A joint venture agreement in biodiscovery was signed with Astra (later merged to AstraZeneca) in 1993. He introduced High Throughput Screening (HTS) technology to Astra and ran the first HTS ever conducted by Astra.
The biodiscovery collections made over the last 18 years provide enough biota samples to sustain biodiscovery for the next hundred years. The collection has been used for over a dozen collaborations since 2007.
He was made a member of the Order of Australia in 2010 for service to scientific research, in the field of chemistry as a leader in the development of therapeutic compounds from marine organisms and plant materials.

Professor Zee Upton - Assistant Dean (Research), Queensland University of Technology
Professor Zee Upton is an internationally renowned biochemist, inventor and tissue engineer best known for her research in growth factors, extracellular matrix proteins and wound repair. She is the Assistant Dean (Research) for the Faculty of Health and Research, Professor within the Institute of Health and Biomedical Innovation leading an interdisciplinary team of 50 researchers. Professor Upton's group is the leading tissue repair program in Australia and a major research partner in the $28M Wound Management Innovation CRC.
Sincer her PhD in Biochemistry in 1994 Professor Upton has attracted over $14M in research funding, produced 65 publications with 1100 citations and achieved 10 patents.
Professor Upton is dynamic, enthusiastic researcher making significant impacts. She displays an outstanding level of high-quality science, innovation, and entrepreneurship. She successfully promotes her discoveries for the practical benefit of patients as well as economic benefit. These exceptional achievements make her a highly deserved nominee for the Queensland Life Science Industry Excellence Award.

 

   
McCullough Robertson

Thank you to our sponsor

  Supporting Partner  
Sanofi Aventis
   
  Supporting Partner  
Queensland Government
   
OHMR
Copyright 2007 by ICMAN5 Login Sitemap Privacy Statement Legal Notice Copyright Disclaimer